Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Stryker (NYSE: SYK), a global leader in medical technologies, has announced its definitive agreement to acquire Inari Medical ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news ...

Current applications of MRI-guided & combined x-ray and MRI catheterization in the literature Pulmonary vascular resistance studies. Pharmacological stress studies (e.g., dobutamine stress studies ...

Pulmonary Computed Tomography Angiogram (PCTA) Pulmonary computed tomography angiogram (PCTA) is considered the first-choice diagnostic imaging technique when a pulmonary embolism is suspected ...

Finally, being able to measure key physiological parameters such as pulmonary blood flow and ventricular volumes during cardiac catheterization is often important, but difficult under x-ray guidance.